Efficacy News and Research

RSS
Booster dose of mRNA vaccine highly effective in preventing SARS-CoV-2 infection

Booster dose of mRNA vaccine highly effective in preventing SARS-CoV-2 infection

Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Single-dose vaccine delivers protection against cervical cancer-causing HPV comparable to 2 or 3-dose regimes

Single-dose vaccine delivers protection against cervical cancer-causing HPV comparable to 2 or 3-dose regimes

The preclinical potential of S. miltiorrhiza extracts for the treatment of COVID-19

The preclinical potential of S. miltiorrhiza extracts for the treatment of COVID-19

Novel transdermal vaccine delivery for COVID-19 and cancer

Novel transdermal vaccine delivery for COVID-19 and cancer

Mayo Clinic researchers devise a combination approach to more effectively target solid tumors

Mayo Clinic researchers devise a combination approach to more effectively target solid tumors

CDC study highlights effectiveness of COVID-19 booster vaccination against reinfection and hospitalization

CDC study highlights effectiveness of COVID-19 booster vaccination against reinfection and hospitalization

Case of probable transmission of tick-borne encephalitis virus from an unvaccinated mother to an infant through breast-feeding

Case of probable transmission of tick-borne encephalitis virus from an unvaccinated mother to an infant through breast-feeding

Research shows effectiveness of a 3rd mRNA COVID-19 vaccine dose

Research shows effectiveness of a 3rd mRNA COVID-19 vaccine dose

mRNA vaccines induce CD8+ T cells that may reduce COVID-19 severity

mRNA vaccines induce CD8+ T cells that may reduce COVID-19 severity

New COVID-19 vaccine induces T-cell immune responses in most patients with B-cell deficiencies

New COVID-19 vaccine induces T-cell immune responses in most patients with B-cell deficiencies

Parallel approach to vaccine trials can lead to faster and more accurate assessment

Parallel approach to vaccine trials can lead to faster and more accurate assessment

Aprotinin could inhibit virus replications by preventing SARS-CoV-2 entry into host cells

Aprotinin could inhibit virus replications by preventing SARS-CoV-2 entry into host cells

Decoy nanoparticles could provide a quick, effective treatment for COVID-19

Decoy nanoparticles could provide a quick, effective treatment for COVID-19

Third dose of messenger RNA vaccines found to increase serological immunity in hematological malignancy patients

Third dose of messenger RNA vaccines found to increase serological immunity in hematological malignancy patients

Early COVID-19 reinfections possible within 60 days of initial infection

Early COVID-19 reinfections possible within 60 days of initial infection

Study finds efficacy of SARS-CoV-2 vaccines reported in Phase 3 trials declines as pandemic prevalence at trial sites increases

Study finds efficacy of SARS-CoV-2 vaccines reported in Phase 3 trials declines as pandemic prevalence at trial sites increases

Exploring vaccine effectiveness against SARS-CoV-2 Omicron and Delta variants in adolescents

Exploring vaccine effectiveness against SARS-CoV-2 Omicron and Delta variants in adolescents

Scientists find critical role for Hippo signaling pathway in COVID-19 pathogenesis

Scientists find critical role for Hippo signaling pathway in COVID-19 pathogenesis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.